Vijaya Diagnostic Centre Management Guidance Tracker
8 forward-looking guidance items tracked across 2 quarters.
Capex
Expansion
Margins
Q3 FY26EBITDA margin guidance of ~40%Active
Despite operating leverage from faster break-even, management guides EBITDA margin at ~40% due to investments in talent and digital.
Q4 FY26FY27 EBITDA margin guidance of 40%+TrackedManagement expects to deliver over 40% EBITDA margin despite new center investments and technology/talent costs.
Growth
Q3 FY26New hubs to break even in 12-14 monthsTracked
Management maintains guidance that new hubs outside Hyderabad will break even within 12-14 months, though recent hubs achieved it in 3 quarters.
Q4 FY26Double-digit revenue growth in Pune for FY27TrackedConfident of double-digit growth in Pune for the full year, driven by network expansion and corporate segment.